K. Danner

Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection

Rodent-borne diseases and their risks for public health

Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies

Bacterial pore-forming hemolysins and their use in the cytosolic delivery of macromolecules

Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine

Prospects for a vaccine against the hepatitis C virus

Regulatory T cells, tumour immunity and immunotherapy

The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?

Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization

Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins

Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein

Design of therapeutic vaccines: hepatitis B as an example

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

Epidemiological pattern of classical Borna disease and regional genetic clustering of Borna disease viruses point towards the existence of to-date unknown endemic reservoir host populations

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

Ventilator-associated Pneumonia

Long-Circulating and Target-Specific Nanoparticles: Theory to Practice

CTLA-4 Blockade Enhances the Therapeutic Effect of an Attenuated Poxvirus Vaccine Targeting p53 in an Established Murine Tumor Model

The Canarypox Virus Vector ALVAC Induces Distinct Cytokine Responses Compared to the Vaccinia Virus-Based Vectors MVA and NYVAC in Rhesus Monkeys

Recombinant modified vaccinia virus Ankara–simian immunodeficiency virusgag polelicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer

Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 ⁺ Lymphocytes

Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster

Yellow fever 17D as a vaccine vector for microbial CTL epitopes

Comparative Efficacy of Recombinant Modified Vaccinia Virus Ankara Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol and/or Env in Macaques Challenged with Pathogenic SIV

MICROBIOLOGIC DIAGNOSIS OF VENTILATOR-ASSOCIATED PNEUMONIA

Induction of Protective Immunity against Malaria by Priming-Boosting Immunization with Recombinant Cold-Adapted Influenza and Modified Vaccinia Ankara Viruses Expressing a CD8⁺-T-Cell Epitope Derived from the Circumsporozoite Protein ofPlasmodium yoelii

[Virologically confirmed outbreak of Borna's disease in a Swiss herd of sheep].

Acceptability of bio-engineered vaccines

[The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)].

Persistent infections caused by Borna virus